Ability to handle stress, depression linked to variations in brain structure and function

October 18, 2007

Researchers at UT Southwestern Medical Center have found in mice that the ability or inability to cope with stress is linked to specific differences in the way brain cells communicate with each other.

Understanding these mechanisms – which are also present in people – may aid scientists in developing methods for humans to boost resilience to stress and depression.

"One of the major insights provided by this work is that resilience to stress is an active process," said Dr. Eric Nestler, chairman of psychiatry and senior author of the study, which appears in the Oct. 19 issue of Cell.

“This means that chronic stress, depression, post-traumatic stress disorder and similar disorders might be treated by promoting the mechanisms that underlie resilience,” said Dr. Nestler.

Mice, like humans, vary widely in their reactions to stress. Some adapt well, while others become timid and appear depressed. While stress is known to play a major role in human mental illness, scientists wonder why some people can cope well with adversity while others do not.

The researchers used male mice that had been inbred to the point that they were genetically identical. They stressed the rodents by placing them in the territory of a larger, aggressive mouse and recorded how this stress affected their ability to interact socially. In a previous study, Dr. Nestler and his colleagues established that mice which repeatedly go through this “social defeat” are a good model for human depression.

In the current study, some of the genetically identical mice interacted with the unfamiliar, more aggressive mouse, while others avoided it and showed submissive behavior.

The researchers classified the mice according to whether they had coped with the stress or not. They found that some showed a long-lasting social withdrawal, while others continued to interact normally with other mice.

The mice that coped less effectively were also less attracted to sugar but more to cocaine than the coping mice, suggesting that there was a link between their vulnerability to stress and substance abuse.

The researchers then examined two areas of the brain that are associated with pleasure and reward, called the ventral tegmental area (VTA) and the nucleus accumbens (NAc).

Neurons in the VTA send chemical signals to the NAc, and the present study shows that in mice experiencing social defeat and depression, these neurons fire faster. Upon firing, the neurons cause the release of a substance called BDNF, a nerve growth factor that the researchers have previously linked to poor coping.

The researchers further found that the vulnerable mice showed an increase in BDNF in the nucleus accumbens. The resilient ones did not, presumably because neurons from their VTAs did not fire as much. When the researchers genetically blocked BDNF in the more timid mice, they became resistant to stress.

“Preventing BDNF signaling to the nucleus accumbens may be a key mechanism of resistance to stress and depression,” Dr. Nestler said.

The researchers also found that better-coping mice had far more genes turned on and off in the VTA and NAc than vulnerable mice. This discovery suggests that successful coping with stress is an active process that involves the regulation of many genes, not just the lack of responses seen in poorly coping animals.

Three of the genes that showed the greatest difference between the two groups of mice coded for potassium channels, molecules that let potassium pass through a nerve cell’s membrane when it fires. The researchers found that the resilient animals had increased activity of the potassium channels, which counters the increased nerve firing, and hence the increase of BDNF release, in the vulnerable mice.

To explore how these results might apply to humans, the researchers obtained brain samples from depressed and non-depressed humans. The depressed people showed a 40 percent increase in BDNF levels in the nucleus accumbens, compared to controls.

From these various findings, the researchers concluded that preventing BDNF release into the nucleus accumbens may be a way to increase coping ability to stress or depression.

“It may be possible to develop compounds that improve one’s ability to cope with stress,” Dr. Nestler said. “But blocking BDNF might also affect other systems, so we must find a way to focus on this single pathway.”

Vaishnav Krishnan, an M.D./Ph.D. student in the Medical Scientist Training Program and lead author of the paper, said, “The study yields significant insights into molecular mechanisms that may underlie individual differences of people in reacting to stressful life events.”

Source: UT Southwestern Medical Center

Explore further: Cell study reveals how head injuries lead to serious brain diseases

Related Stories

Cell study reveals how head injuries lead to serious brain diseases

November 16, 2018
UCLA biologists have discovered how head injuries adversely affect individual cells and genes that can lead to serious brain disorders. The life scientists provide the first cell "atlas" of the hippocampus—the part of the ...

Studies highlight lasting effects of early life stress on the genome, gut, and brain

November 5, 2018
Excessive stress during fetal development or early childhood can have long-term consequences for the brain, from increasing the likelihood of brain disorders and affecting an individual's response to stress as an adult to ...

Individual stress susceptibility and glucose metabolism are linked to brain function

October 25, 2018
Chronic stress is a well-known risk factor for the development of psychiatric illnesses including depression disorders. The brain requires a great deal of glucose, and stress is known to alter glucose metabolism. However, ...

Stress protein could be used to prevent childhood obesity in males

October 31, 2018
New research published in The Journal of Physiology identifies a novel protein that reduces the likelihood of obesity and related metabolic disorders in boys.

Scientists overturn odds to make Parkinson's discovery

November 7, 2018
Scientists at the University of Dundee have confirmed that a key cellular pathway that protects the brain from damage is disrupted in Parkinson's patients, raising the possibility of new treatments for the disease.

Researchers reveal why Hippo pathway may have an outsized effect on solid tumor

October 31, 2018
Like detectives tracking a serial killer, St. Jude Children's Research Hospital scientists have identified a novel mechanism that may help promote the growth and spread of solid tumors. The findings appeared online Oct. 25 ...

Recommended for you

RNAi therapy mitigates preeclampsia symptoms

November 19, 2018
A collaboration of scientists from the University of Massachusetts Medical School, Beth Israel Deaconess Medical Center and Western Sydney University, have shown that an innovative new type of therapy using small interfering ...

Skeletal imitation reveals how bones grow atom-by-atom

November 19, 2018
Researchers from Chalmers University of Technology, Sweden, have discovered how our bones grow at an atomic level, showing how an unstructured mass orders itself into a perfectly arranged bone structure. The discovery offers ...

Signal peptides' novel role in glutamate receptor trafficking and neural synaptic activity

November 19, 2018
Glutamate is the major excitatory neurotransmitter in the brain, and the postsynaptic expression level of glutamate receptors is a critical factor in determining the efficiency of information transmission and the activity ...

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

New insights into how an ordinary stem cell becomes a powerful immune agent

November 19, 2018
How do individual developing cells choose and commit to their "identity"—to become, for example, an immune cell, or a muscle cell, or a neuron?

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.